DCAL logo

Dishman Carbo Amcis LTD

DCAL·NSE·
180.84 -0.99 (-0.54%)
Market Cap2855.49 Cr
PE Ratio29.07
Volume87,390
Day High - Low183.62 - 178.81
52W High-Low321.95 - 128.50
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
1.58%
Weak
P/E
29.07x
Fair
Debt / Equity
0.16
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day178.81
183.62
52W128.50
321.95
DocStoX take

Supported by growth (7.6) and valuation (7.3), but held back by momentum (1.7). Growth looks strong at 7.6, but that is offset by momentum at 1.7 and quality at 2.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.6
/10
Weak
Quality
Weak
ROE 1.6%
Valuation
Fair
P/E 29.1×
Growth
Strong
Revenue +8.9% 5Y CAGR
Risk
Elevated
D/E 0.16
Momentum
Weak
27% of 52-week range

At a glance

Market Cap
₹2,855 Cr
52W High / Low
₹322 / ₹129
Dividend Yield
0.00%
Promoter Holding
59.32%
EPS (TTM)
₹6.22
Book Value
₹426.00

Key highlights

  • Profit compounding 58% a year
  • Low leverage — D/E 0.16
  • Loss-making in some of the last 5 years
  • Quality is weak (2.2/10)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

DISHMAN CARBO AMCIS LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.